Oversaw clinical trials in neuroscience, oncology, and immunology—including corporate priority trials in multiple sclerosis, ALS, rheumatoid arthritis, plaque psoriasis, childhood myopia, non-opioid pain management, melanoma, and prostate/colorectal cancers. Each clinical trial spanned 5 to 15 countries and engaged over 30 external vendors.

Brings rare 360° perspective with hands-on experience at investigator sites, CROs, and sponsor companies—enabling strategic oversight and highly collaborative trial management.

Executed a site activation acceleration plan, including:

Completed regulatory submissions to FDA, EMA, Health Canada and other global authorities two months ahead of schedule, enabling early trial launches and seamless Health Authority engagements.

Achieved corporate study enrollment targets three months in advance, contributing to accelerated trial timelines and recognition by senior leadership.

Designed and implemented a screen failure analysis tool adopted across teams; delivered risk-mitigation strategies for trial kits and supply delays and complex study startup challenges.

Mentored fellow Clinical Trial Managers and led global training sessions on clinical trial management systems and tools; served as subject matter expert in site startup, TMF inspection readiness, protocol deviations and issue management, and faster trial execution.

Multiple-time recipient of various company awards for excellence in operational execution and team leadership.